Flamingo gets grant from VLAIO to accelerate RNA-focused oncology portfolio
The grant comes after Flamingo announced a deal in March 2023 to merge its operations with Dynacurez.
Agilent Benefits of Quality Control WP
VaxEquity secures UK grant to expand RNA manufacturing capability
AION Labs and BioMed X launch sixth challenge for AI-driven drug discovery
Ochre Bio raises funds to develop RNA therapies for liver diseases
CAMP4’s $100m Series B backs regulatory RNA-led efforts in urea cycle disorders
Nokia Bell Labs and Equideum Partner to aggregate, optimize and analyze health data
Magazine: Mapping the RNA therapeutics R&D landscape in 2022
Mapping the RNA therapeutics R&D landscape in 2022
